Next Generation Sequencing Market by Type, Application, End Users, Key Players and Regions - Global Industry Analysis & Forecast to 2027
Published On : August 2022 Pages : 145 Category: Pharma & Healthcare Report Code : HC0817398
The global Next Generation Sequencing Market is valued at USD XX billion in 2021 and is projected to reach USD XX billion by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.
The report exhibit detail coverage of Next Generation Sequencing industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2017-2022. This research study of Next Generation Sequencing Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global Next Generation Sequencing Market for 2017-2022.
Crystal Market Research envisions that the span of the Next Generation Sequencing Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.
Our research study analyses the size of the global market of Next Generation Sequencing in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the Next Generation Sequencing Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.
To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the Next Generation Sequencing Market on the basis of fabric, product, application, and region:
By Region
- North America (US, Canada)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Mexico, Columbia, Rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA)
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Illumina
- F. Hoffman-La Roche Ltd.
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Oxford Nanopore Technologies
- PierianDx
- Genomatix GmbH
- DNASTAR, Inc.
- Perkin Elmer, Inc.
- Eurofins GATC Biotech GmbH
- BGI
Market Classification
· Next Generation Sequencing Market, By Type, Estimates and Forecast, 2017-2022 ($Million)
o NGS Consumables
o Sequencing Services
o Presequencing Products & Services
o NGS Platforms
o Bioinformatics
· Next Generation Sequencing Market, By Application, Estimates and Forecast, 2017-2022 ($Million)
o Oncology
o Clinical Investigation
o Reproductive Health
o HLA Typing/Immune System Monitoring
o Metagenomics, Epidemiology & Drug Development
o Agrigenomics & Forensics
o Consumer Genomics
· Next Generation Sequencing Market, By End User, Estimates and Forecast, 2017-2022 ($Million)
o Academic Institutes & Research Centers
o Pharmaceutical & Biotechnology Companies
o Hospitals & Clinics
o Others
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Data Mining
1.2.2. Market Modeling and Forecasting
1.2.3. Data Validation
1.2.4. Industry Analysis
2. Market Dashboard
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
4. Next Generation Sequencing Market, By Type
4.1. Introduction
4.2. Next Generation Sequencing Market and Market Growth Rate By Type (2017-2022)
4.3. NGS Consumables
4.3.1. Global NGS Consumables Market and Growth Rate (2017-2022)
4.3. Sequencing Services
4.3.1. Global Sequencing Services Market and Growth Rate (2017-2022)
4.3. Presequencing Products & Services
4.3.1. Global Presequencing Products & Services Market and Growth Rate (2017-2022)
4.3. NGS Platforms
4.3.1. Global NGS Platforms Market and Growth Rate (2017-2022)
4.3. Bioinformatics
4.3.1. Global Bioinformatics Market and Growth Rate (2017-2022)
5. Next Generation Sequencing Market, By Application
5.1. Introduction
5.2. Next Generation Sequencing Market and Market Growth Rate By Application (2017-2022)
5.3. Oncology
5.3.1. Global Oncology Market and Growth Rate (2017-2022)
5.3. Clinical Investigation
5.3.1. Global Clinical Investigation Market and Growth Rate (2017-2022)
5.3. Reproductive Health
5.3.1. Global Reproductive Health Market and Growth Rate (2017-2022)
5.3. HLA Typing/Immune System Monitoring
5.3.1. Global HLA Typing/Immune System Monitoring Market and Growth Rate (2017-2022)
5.3. Metagenomics, Epidemiology & Drug Development
5.3.1. Global Metagenomics, Epidemiology & Drug Development Market and Growth Rate (2017-2022)
5.3. Agrigenomics & Forensics
5.3.1. Global Agrigenomics & Forensics Market and Growth Rate (2017-2022)
5.3. Consumer Genomics
5.3.1. Global Consumer Genomics Market and Growth Rate (2017-2022)
6. Next Generation Sequencing Market, By End User
6.1. Introduction
6.2. Next Generation Sequencing Market and Market Growth Rate By End User (2017-2022)
6.3. Academic Institutes & Research Centers
6.3.1. Global Academic Institutes & Research Centers Market and Growth Rate (2017-2022)
6.3. Pharmaceutical & Biotechnology Companies
6.3.1. Global Pharmaceutical & Biotechnology Companies Market and Growth Rate (2017-2022)
6.3. Hospitals & Clinics
6.3.1. Global Hospitals & Clinics Market and Growth Rate (2017-2022)
6.3. Others
6.3.1. Global Others Market and Growth Rate (2017-2022)
7. Next Generation Sequencing Market, By Region
7.1. Introduction
7.2. Next Generation Sequencing Market and Growth Rate By Regions
6.3. North America
7.3.1. North America Next Generation Sequencing Market and Growth Rate (2017-2022))
7.3.2. North America Next Generation Sequencing Market By Type (2017-2022)
7.3.2. North America Next Generation Sequencing Market By Application (2017-2022)
7.3.2. North America Next Generation Sequencing Market By End User (2017-2022)
7.3.4. North America Next Generation Sequencing Market By Country (2017-2022)
7.3.5. United States
7.3.5.1.United States Next Generation Sequencing Market and Growth Rate (2017-2022)
7.3.5.2.United States Next Generation Sequencing Market By Type (2017-2022)
7.3.5.2.United States Next Generation Sequencing Market By Application (2017-2022)
7.3.5.2.United States Next Generation Sequencing Market By End User (2017-2022)
7.3.5. Canada
7.3.5.1.Canada Next Generation Sequencing Market and Growth Rate (2017-2022)
7.3.5.2.Canada Next Generation Sequencing Market By Type (2017-2022)
7.3.5.2.Canada Next Generation Sequencing Market By Application (2017-2022)
7.3.5.2.Canada Next Generation Sequencing Market By End User (2017-2022)
6.3. Europe
8.3.1. Europe Next Generation Sequencing Market and Growth Rate (2017-2022))
8.3.2. Europe Next Generation Sequencing Market By Type (2017-2022)
8.3.2. Europe Next Generation Sequencing Market By Application (2017-2022)
8.3.2. Europe Next Generation Sequencing Market By End User (2017-2022)
8.3.4. Europe Next Generation Sequencing Market By Country (2017-2022)
8.3.5. Germany
8.3.5.1.Germany Next Generation Sequencing Market and Growth Rate (2017-2022)
8.3.5.2.Germany Next Generation Sequencing Market By Type (2017-2022)
8.3.5.2.Germany Next Generation Sequencing Market By Application (2017-2022)
8.3.5.2.Germany Next Generation Sequencing Market By End User (2017-2022)
8.3.5. France
8.3.5.1.France Next Generation Sequencing Market and Growth Rate (2017-2022)
8.3.5.2.France Next Generation Sequencing Market By Type (2017-2022)
8.3.5.2.France Next Generation Sequencing Market By Application (2017-2022)
8.3.5.2.France Next Generation Sequencing Market By End User (2017-2022)
8.3.5. UK
8.3.5.1.UK Next Generation Sequencing Market and Growth Rate (2017-2022)
8.3.5.2.UK Next Generation Sequencing Market By Type (2017-2022)
8.3.5.2.UK Next Generation Sequencing Market By Application (2017-2022)
8.3.5.2.UK Next Generation Sequencing Market By End User (2017-2022)
8.3.5. Russia
8.3.5.1.Russia Next Generation Sequencing Market and Growth Rate (2017-2022)
8.3.5.2.Russia Next Generation Sequencing Market By Type (2017-2022)
8.3.5.2.Russia Next Generation Sequencing Market By Application (2017-2022)
8.3.5.2.Russia Next Generation Sequencing Market By End User (2017-2022)
8.3.5. Italy
8.3.5.1.Italy Next Generation Sequencing Market and Growth Rate (2017-2022)
8.3.5.2.Italy Next Generation Sequencing Market By Type (2017-2022)
8.3.5.2.Italy Next Generation Sequencing Market By Application (2017-2022)
8.3.5.2.Italy Next Generation Sequencing Market By End User (2017-2022)
8.3.5. Rest of Europe
8.3.5.1.Rest of Europe Next Generation Sequencing Market and Growth Rate (2017-2022)
8.3.5.2.Rest of Europe Next Generation Sequencing Market By Type (2017-2022)
8.3.5.2.Rest of Europe Next Generation Sequencing Market By Application (2017-2022)
8.3.5.2.Rest of Europe Next Generation Sequencing Market By End User (2017-2022)
6.3. Asia-Pacific
9.3.1. Asia-Pacific Next Generation Sequencing Market and Growth Rate (2017-2022))
9.3.2. Asia-Pacific Next Generation Sequencing Market By Type (2017-2022)
9.3.2. Asia-Pacific Next Generation Sequencing Market By Application (2017-2022)
9.3.2. Asia-Pacific Next Generation Sequencing Market By End User (2017-2022)
9.3.4. Asia-Pacific Next Generation Sequencing Market By Country (2017-2022)
9.3.5. China
9.3.5.1.China Next Generation Sequencing Market and Growth Rate (2017-2022)
9.3.5.2.China Next Generation Sequencing Market By Type (2017-2022)
9.3.5.2.China Next Generation Sequencing Market By Application (2017-2022)
9.3.5.2.China Next Generation Sequencing Market By End User (2017-2022)
9.3.5. Japan
9.3.5.1.Japan Next Generation Sequencing Market and Growth Rate (2017-2022)
9.3.5.2.Japan Next Generation Sequencing Market By Type (2017-2022)
9.3.5.2.Japan Next Generation Sequencing Market By Application (2017-2022)
9.3.5.2.Japan Next Generation Sequencing Market By End User (2017-2022)
9.3.5. Korea
9.3.5.1.Korea Next Generation Sequencing Market and Growth Rate (2017-2022)
9.3.5.2.Korea Next Generation Sequencing Market By Type (2017-2022)
9.3.5.2.Korea Next Generation Sequencing Market By Application (2017-2022)
9.3.5.2.Korea Next Generation Sequencing Market By End User (2017-2022)
9.3.5. India
9.3.5.1.India Next Generation Sequencing Market and Growth Rate (2017-2022)
9.3.5.2.India Next Generation Sequencing Market By Type (2017-2022)
9.3.5.2.India Next Generation Sequencing Market By Application (2017-2022)
9.3.5.2.India Next Generation Sequencing Market By End User (2017-2022)
9.3.5. Southeast Asia
9.3.5.1.Southeast Asia Next Generation Sequencing Market and Growth Rate (2017-2022)
9.3.5.2.Southeast Asia Next Generation Sequencing Market By Type (2017-2022)
9.3.5.2.Southeast Asia Next Generation Sequencing Market By Application (2017-2022)
9.3.5.2.Southeast Asia Next Generation Sequencing Market By End User (2017-2022)
9.3.5. Rest of Asia-Pacific
9.3.5.1.Rest of Asia-Pacific Next Generation Sequencing Market and Growth Rate (2017-2022)
9.3.5.2.Rest of Asia-Pacific Next Generation Sequencing Market By Type (2017-2022)
9.3.5.2.Rest of Asia-Pacific Next Generation Sequencing Market By Application (2017-2022)
9.3.5.2.Rest of Asia-Pacific Next Generation Sequencing Market By End User (2017-2022)
6.3. South America
10.3.1. South America Next Generation Sequencing Market and Growth Rate (2017-2022))
10.3.2. South America Next Generation Sequencing Market By Type (2017-2022)
10.3.2. South America Next Generation Sequencing Market By Application (2017-2022)
10.3.2. South America Next Generation Sequencing Market By End User (2017-2022)
10.3.4. South America Next Generation Sequencing Market By Country (2017-2022)
10.3.5. Brazil
10.3.5.1.Brazil Next Generation Sequencing Market and Growth Rate (2017-2022)
10.3.5.2.Brazil Next Generation Sequencing Market By Type (2017-2022)
10.3.5.2.Brazil Next Generation Sequencing Market By Application (2017-2022)
10.3.5.2.Brazil Next Generation Sequencing Market By End User (2017-2022)
10.3.5. Mexico
10.3.5.1.Mexico Next Generation Sequencing Market and Growth Rate (2017-2022)
10.3.5.2.Mexico Next Generation Sequencing Market By Type (2017-2022)
10.3.5.2.Mexico Next Generation Sequencing Market By Application (2017-2022)
10.3.5.2.Mexico Next Generation Sequencing Market By End User (2017-2022)
10.3.5. Columbia
10.3.5.1.Columbia Next Generation Sequencing Market and Growth Rate (2017-2022)
10.3.5.2.Columbia Next Generation Sequencing Market By Type (2017-2022)
10.3.5.2.Columbia Next Generation Sequencing Market By Application (2017-2022)
10.3.5.2.Columbia Next Generation Sequencing Market By End User (2017-2022)
10.3.5. Rest of South America
10.3.5.1.Rest of South America Next Generation Sequencing Market and Growth Rate (2017-2022)
10.3.5.2.Rest of South America Next Generation Sequencing Market By Type (2017-2022)
10.3.5.2.Rest of South America Next Generation Sequencing Market By Application (2017-2022)
10.3.5.2.Rest of South America Next Generation Sequencing Market By End User (2017-2022)
6.3. Middle East and Africa
11.3.1. Middle East and Africa Next Generation Sequencing Market and Growth Rate (2017-2022))
11.3.2. Middle East and Africa Next Generation Sequencing Market By Type (2017-2022)
11.3.2. Middle East and Africa Next Generation Sequencing Market By Application (2017-2022)
11.3.2. Middle East and Africa Next Generation Sequencing Market By End User (2017-2022)
11.3.4. Middle East and Africa Next Generation Sequencing Market By Country (2017-2022)
11.3.5. Saudi Arabia
11.3.5.1.Saudi Arabia Next Generation Sequencing Market and Growth Rate (2017-2022)
11.3.5.2.Saudi Arabia Next Generation Sequencing Market By Type (2017-2022)
11.3.5.2.Saudi Arabia Next Generation Sequencing Market By Application (2017-2022)
11.3.5.2.Saudi Arabia Next Generation Sequencing Market By End User (2017-2022)
11.3.5. United Arab Emirates
11.3.5.1.United Arab Emirates Next Generation Sequencing Market and Growth Rate (2017-2022)
11.3.5.2.United Arab Emirates Next Generation Sequencing Market By Type (2017-2022)
11.3.5.2.United Arab Emirates Next Generation Sequencing Market By Application (2017-2022)
11.3.5.2.United Arab Emirates Next Generation Sequencing Market By End User (2017-2022)
11.3.5. South Africa
11.3.5.1.South Africa Next Generation Sequencing Market and Growth Rate (2017-2022)
11.3.5.2.South Africa Next Generation Sequencing Market By Type (2017-2022)
11.3.5.2.South Africa Next Generation Sequencing Market By Application (2017-2022)
11.3.5.2.South Africa Next Generation Sequencing Market By End User (2017-2022)
11.3.5. Rest of Middle East and Africa
11.3.5.1.Rest of Middle East and Africa Next Generation Sequencing Market and Growth Rate (2017-2022)
11.3.5.2.Rest of Middle East and Africa Next Generation Sequencing Market By Type (2017-2022)
11.3.5.2.Rest of Middle East and Africa Next Generation Sequencing Market By Application (2017-2022)
11.3.5.2.Rest of Middle East and Africa Next Generation Sequencing Market By End User (2017-2022)
7. Company Profiles
7.1. Illumina
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. F. Hoffman-La Roche Ltd.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. QIAGEN
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Thermo Fisher Scientific, Inc.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Bio-Rad Laboratories, Inc.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Oxford Nanopore Technologies
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. PierianDx
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Genomatix GmbH
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. DNASTAR, Inc.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Perkin Elmer, Inc.
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. Eurofins GATC Biotech GmbH
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
7.1. BGI
7.1.1. Business Overview
7.1.1. Service Portfolio
7.1.1. Strategic Developments
7.1.1. Financial Overview
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|